Health-Related Quality of Life and Satisfaction With Health Care: Relation to Clinical Stage in Mexican Patients With Multiple Myeloma

Cancer Control : Journal of the Moffitt Cancer Center
Luz-Ma-Adriana Balderas-PeñaBenjamín Rubio-Jurado

Abstract

Multiple myeloma (MM) is characterized by bone pain, pathologic fractures, bone destruction, and secondary hypercalcemia, all these conditions impact on health-related quality of life of patients. The objective was to evaluate the global health state and health-related quality of life in a group of patients with MM who attended a tertiary health-care center of the Instituto Mexicano del Seguro Social in Mexico, through the questionnaires designed by European Organization for Research and Treatment of Cancer (EORTC) quality of life group. Exploratory cross-sectional study in patients with MM treated in a Department of Hematology in a High-Specialty Medical Unit was conducted. Patients older than 18 years of age, men and women, were selected, and their informed written consent was obtained. We included all consecutive cases treated from January 2012 to December 2014. Questionnaires EORTC QLQ-C30, EORTC QLQ-MY20, and EORTC IN-PATSAT-32 were used. We studied 37 patients, 19 (51%) men and 18 women. The mean age was 61.9 years. Twenty-two (59.46%) patients presented with clinical stage III. The mean time for diagnosis was 33.11 months. The most used first-line treatment schedule was melphalan/prednisone/thalidomide (15; 40%). The glo...Continue Reading

References

Jan 17, 2003·Mayo Clinic Proceedings·Robert A KylePhilip R Greipp
Mar 3, 2004·Cancer Research·Rafael FonsecaHerve Avet-Loiseau
Oct 29, 2004·The New England Journal of Medicine·Robert A Kyle, S Vincent Rajkumar
Sep 27, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A BrédartUNKNOWN European Organisation for Research and Treatment of Cancer Quality of Life Group and Quality of Life Unit
Jul 21, 2006·Leukemia·B G M DurieUNKNOWN International Myeloma Working Group
Jun 19, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K CocksUNKNOWN EORTC Quality of Life Group
Aug 30, 2008·The New England Journal of Medicine·Jesús F San MiguelUNKNOWN VISTA Trial Investigators
Mar 17, 2009·European Journal of Haematology·Anna T JohnsenMogens Groenvold
Mar 18, 2011·The New England Journal of Medicine·Antonio Palumbo, Kenneth Anderson
Aug 24, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Luz-Ma-Adriana Balderas-PeñaGilberto Morgan-Villela
Mar 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeff A SloanPing Yang
Apr 10, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A BrédartS Dolbeault
Jun 8, 2013·Revista da Escola de Enfermagem da U S P·Viviane AndradeElizabeth Barichello
Jun 28, 2013·BMJ : British Medical Journal·Dean Smith, Kwee Yong
Jul 13, 2013·Health and Quality of Life Outcomes·Salvador Pita-FernándezAlejandro Pazos-Sierra
Oct 15, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Karin JordanFaith E Davies
Oct 15, 2013·Psycho-oncology·Allison J ApplebaumWilliam Breitbart
Oct 16, 2013·Cancer·Chantal QuintenUNKNOWN Patient Reported Outcomes and Behavioral Evidence (PROBE) and the European Organization for Research and Treatment of Cancer
Oct 22, 2013·The American Journal of Hospice & Palliative Care·Raghava R Induru, Declan Walsh
Jan 5, 2014·Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology·Melda CömertGüray Saydam
Aug 17, 2014·Clinical Lymphoma, Myeloma & Leukemia·Jonathan D CicciHank van Deventer
Jan 8, 2015·Annals of Hematology·José Ramiro Espinoza-ZamoraLuis F Oñate-Ocaña
May 30, 2015·Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia·Samir H Almueilo

❮ Previous
Next ❯

Methods Mentioned

BETA
ISS

Software Mentioned

IMSS
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.